A 2026 review of electroacupuncture for depression found a familiar split: mechanistic evidence is rich, but clinical proof remains uneven because representative trials ranged from 65 to 270 participants, used different sham or drug comparators, and often failed to connect stimulation parameters with biological endpoints.1 Electroacupuncture is plausible as a subtype-matched neuromodulation strategy, but it …
A 2026 preclinical study found that 25C-NBF, a selective 5-HT2A psychedelic phenethylamine, increased plasticity-related markers and produced rapid antidepressant-like effects in male rodents, while showing no detected reward or reinforcement signal in the models tested. Research Highlights 25C-NBF was preclinical: Nadal-Gratacos et al. tested cells, male mice, and male rats, not patients with depression.1 5-HT2A …
A 7-day mind-body retreat study in 20 healthy adults found pre/post shifts across fMRI brain networks and plasma biology, with p values as low as 0.000003.1 Those numbers are striking, but the design was observational, so the honest reading is biological signal without causal isolation. Research Highlights Neural signal was broad: Meditation-state fMRI showed lower …
A 91-player adolescent football preprint mapped head-impact-related cortical slowing onto brain receptor and gene-expression maps: concussion-related slowing aligned with norepinephrine transporter density, r = 0.43, and alpha-4 beta-2 nicotinic receptor density, r = 0.50, while aligning inversely with dopamine D2, BDNF, and APOE maps.1 The result is a mechanistic clue about where head-impact physiology may …
A 2026 randomized sham-controlled trial in 76 adults with primary insomnia found an 8-week Sancai acupuncture protocol reduced post-treatment Insomnia Severity Index scores to 7.80 vs. 16.45 with sham acupuncture, while total sleep time increased to 366.83 minutes vs. 287.97 minutes.1 Research Highlights Insomnia severity fell far more with real acupuncture: Zhao et al. randomized …
Exercise reliably reduces depression and anxiety symptoms — but the cardio-vs-resistance gap and antidepressant parity claims are overstated.
Parkinson’s disease (PD), a degenerative disorder that predominantly affects the motor system, has long been a challenging condition to manage due to its complex pathology and the limited efficacy of available treatments. However, recent research presents a beacon of hope through a novel combined therapy targeting the core of Parkinson’s disease’s neuronal degradation. This innovative …